SEGMENT INFORMATION (Narrative) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Revenue, Major Customer [Line Items]
Restructuring charges	$ 3,195
Services Segment [Member]
Revenue, Major Customer [Line Items]
Restructuring charges	1,360
Corporate [Member]
Revenue, Major Customer [Line Items]
Restructuring charges	$ 1,835
Gilead Sciences, Inc. [Member]
Revenue, Major Customer [Line Items]
Percentage of total revenues	7.30%	14.50%
Percentage of trade accounts receivable	7.40%	6.30%
Pfizer, Inc. [Member]
Revenue, Major Customer [Line Items]
Percentage of total revenues	3.40%	5.20%
Percentage of trade accounts receivable	8.40%	4.20%